Is neoadjuvant androgen deprivation therapy beneficial in prostate cancer treated with definitive radiotherapy?
Keun-Yong Eom, Sung W Ha, Eunsik Lee, Cheol Kwak, Sang Eun Lee
Radiat Oncol J. 2014;32(4):247-255. Published online 2014 Dec 30 DOI: https://doi.org/10.3857/roj.2014.32.4.247
Citations to this article as recorded by 
Neoadjuvant hormone therapy for patients with high-risk prostate cancer: a systematic review and meta-analysis
Wen Liu, Yu Yao, Xue Liu, Yong Liu, Gui-Ming Zhang
Asian Journal of Andrology.2021; 23(4): 429. CrossRef
Testicular vs adrenal sources of hydroxy-androgens in prostate cancer
Tianzhu Zang, Mary-Ellen Taplin, Daniel Tamae, Wanling Xie, Clementina Mesaros, Zhenwei Zhang, Glenn Bubley, Bruce Montgomery, Steven P Balk, Elahe A Mostaghel, Ian A Blair, Trevor M Penning
Endocrine-Related Cancer.2017; 24(8): 393. CrossRef